Pacira BioSciences Inc (NASDAQ: PCRX) stock enjoyed a major increase of 14.7% on 4/8/25. The shares closed at $26.27. Moreover, this advance was accompanied by exceptionally high trading volume at 413% of normal. The stock has been exceptionally strong relative to the market over the last nine months and has risen 5.7% during the last week.
Current PriceTarget Research Rating
Pacira BioSciences has a current Value Trend Rating of B (Positive). The Value Trend Rating reflects inconsistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Pacira BioSciences has a neutral Appreciation Score of 51 but a good Power Rating of 82, and the Positive Value Trend Rating results.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of B. This review will be completed in the next several days.
Be the first to comment